Image default
Business Partnerships Scale-Up

Global Bioenergies swoop for Dutch conversion technology start-up Syngip.

Resized Co2 Towers.jpgGlobalBioenergies has announced it is set to purchase industrial biotech start-up Syngip, which has developed a process to convert gaseous carbon sources such as CO2, CO, and industrial emissions such as syngas, into various valuable chemical compounds. To this end, the company has identified a specific micro-organism capable of growing using these gaseous carbon sources as its sole feedstock, and has developed genetic tools to allow the implementation of artificial metabolic pathways into it. Its recent work has been directed to the implementation of metabolic pathways leading to light olefins, major petrochemical molecules, which include isobutene.

Founded during October 2008 in Evry, France, GlobalBioenergies ( @GlobalBioenergi)has set the diversification of feedstocks usable in its isobutene process as its new Research and Development frontier. CO2, CO and syngas cause global warming, but represent an abundant and cheap source of carbon. The acquisition of Syngip greatly accelerates the development of a 3rdgeneration isobutene process based on the use of such resources, an aim that has been part of GlobalBioenergies strategy for several years. All Syngip employees would be dedicated, as part of the Global Bioenergies group, to developing such a process.

Bernhard Gntner, CEO of Syngip, commented on the announcement:There are clear synergies between Syngip and GlobalBioenergies. Combining our technology with Global Bioenergies capabilities in metabolic engineering, industrial fermentation and chemical engineering will be a key factor in moving to the industrialization phase. We lose our independencBio-Based Live Europe (2017)e, but it is worth it: the entrepreneurial spirit that drives GlobalBioenergies on a daily basis is a very important value for me and all of Syngips employees. (Read an exclusive Bio-Based World News interview with Bernhard here.)

Frdric Pques, Chief Operations Officer of GlobalBioenergies, states that: This Syngip acquisition project is part of our general open innovation strategy, where we look outside of our company for technical elements to reinforce our Group.

Marc Delcourt, CEO of GlobalBioenergies, concludes: We continue to achieve our aim of diversifying the feedstocks usable in our process. This acquisition will increase both our competitiveness and our environmental impact.

For more bio-based business developments like this…

Audi and Global Bioenergies to further explore drop-in biofuel.

Ask the Industry: Bernhard Guentner, Chief Executive Officer, Syngip.

Global Bioenergies, LOral and partners announce bio-isobutene plantproject.

Industry consortium forms to focus on commercializing bio-based gasoline.

Related posts

Bio-based firms step up to help global fight against coronavirus

Liz Gyekye

Avantium’s latest acquisition is “an important step… to create and commercialise breakthrough technologies.”

Emily Odowd

Neste to boost biofuel production by 1m tonnes with opening of Singapore refinery.

Dave Songer

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More